This review outlines the basic principles and pharmacologic management strategies for promoting pulmonary vasodilation in patients with perioperative pulmonary hypertension.
Offers a synthesis of perioperative pulmonary hypertension management strategies; leaves open the need for prospective trials to refine recommendations.
Perioperative pulmonary hypertension can originate from an established disease or acutely develop within the surgical setting. Patients with increased pulmonary vascular resistance are consequently at greater risk for complications. Despite the various specific therapies available, the ideal therapeutic approach in this patient population is not currently clear. This article describes the basic principles of perioperative pulmonary hypertension and reviews the different classes of agents used to promote pulmonary vasodilation in the surgical setting.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: